Recruiting subjects for ongoing Phase III hepatitis C virus (HCV) trials just got a lot harder. translation
About this Blog
BioWorld Perspectives is the official blog for news, analysis, debates, commentary and camaraderie related to the development of biotechnology drugs.
Subscribe to our Blog
Recent Posts
Categories
- Accelerated approval (2)
- acquisition (1)
- Antibody (2)
- Autism (1)
- Big pharma (23)
- Biologic (4)
- Biosimilar (6)
- Biotech conferences (4)
- Biotechnology (80)
- BLA (3)
- Cancer (15)
- Cardiovascular (2)
- China (3)
- Clinic (3)
- Clinical Trial (12)
- Collaboration (5)
- Complete Response Letter (3)
- Deals (6)
- Drug Approval (11)
- drug importation (1)
- European Medicines Agency (4)
- FDA (15)
- Financing (19)
- Gene Therapy (4)
- Genomics (4)
- Healthcare reform (4)
- immunotherapy (4)
- IND (2)
- Investigational New Drug Application (3)
- IPO (4)
- License (2)
- M&A (3)
- NDA (3)
- neurology (1)
- neuroprostheses (1)
- neuroprosthetic (1)
- New Drug Application (6)
- Orphan disease (6)
- pandemic (1)
- Patents (3)
- PDUFA (3)
- Personalized medicine (4)
- Pharmaceutical (17)
- Phase I (5)
- Phase II (4)
- Phase III (6)
- Pipeline (6)
- Preclinical (2)
- Rare disease (3)
- Reimbursement (8)
- RNAi (2)
- Series A (1)
- Shareholder value (1)
- siRNA (1)
- Stem cell (2)
- Supplemental new drug application (2)
- Uncategorized (8)
- Vaccine (1)
- venture captial (5)
- Video (5)
- virus (1)
Tags
ABH
Adam Feuerstein
Amgen Inc
AMGN
ASCO
Baird Co
Bill Gates
BIO
Biotechnology Industry Organization
bioworld
Cell Therapeutics Inc
CEO
China
Christopher Raymond
Clovis Oncology Inc
Cynthia Robbins Roth
Dendreon Corp
DNA
EST
FDA
HCV
Henry David Thoreau
HIV
IPO
Janssen Labs
Mari Serebrov
MBA
Metabolex Inc
New York
NIH
Nobel Prize
Portola Pharmaceuticals Inc
PR
Rigel Pharmaceuticals Inc
ROI
San Diego
San Francisco
Seattle Genetics
Seattle Genetics Inc
SEC
Targacept Inc
UK
VC
Vertex Pharmaceutical Inc
Vivus Inc
Recommended Blogs
Recommended Organizations
Twitter Updates
Part of Thompson Media Group LLC: Thompson.com | Sheshunoff.com | ASPratt.com | BioWorld.com | CMEweb.com | Performanceweb.org | ASMIweb.com
© Copyright 2012 | BioWorld
© Copyright 2012 | BioWorld
Bad Behavior has blocked 819 access attempts in the last 7 days.
Join the Conversation